FSTX   $7.12  0.0 Market Closed

F-star Therapeutics Inc
Total Cash 35.57M
totalCashPerShare 1.618
EBITDA -33.68M
Total Debt 12.68M
quickRatio 2.979
currentRatio 3.381
Total Revenue 21.18M
debtToEquity 22.266
Revenue/Share 0.994
ROA -0.21631001
ROE -0.60874003
grossProfits 21.17M
freeCashflow -20.46M
operatingCashflow -37.91M
earningsGrowth
revenueGrowth 0.498
grossMargins 1.0
ebitdaMargins -1.59055
operatingMargins -1.62229
profitMargins -2.1132002
enterpriseValue 133.62M
forwardPE -2.0697675
floatShares 21.58M
sharesOutstanding 21.98M
sharesShort 1.23M
sharesShortPriorMonth 909.60K
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.45%
Short Ratio help_outline 2.59%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 2.59
Price To Book help_outline 2.75
earningsQuarterlyGrowth
netIncomeToCommon -44.75M
trailingEps -1.83%
forwardEps -3.44%
enterpriseToEbitda -3.97
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.39 4Q 2022
institutionsCount 69
lastUpdated April 22, 2023, 2:11 p.m.